- Messages
- 704
Thanks to everyone who contributed to the thread.
I wrote to Diabetes UK, noting from their 2013 report on access to test-strips (thanks to Phoenix for the link) the extraordinary range of misleading responses given by HCPs in telling people why test strips cannot be provided, and noting especially those cases where diabetics are told that testing is unnecessary or even positively harmful. I remarked that this meant that not only are diabetics not receiving test strips, but they are being positively dissuaded from buying their own and using them to monitor their condition. Using examples from this thread, I commented that the reasons given (stress, pain from use of lancets or risk of infection, ‘testing does not work’, etc) ranged from the misleading to the outrageously false. I suggested that, even if the financial problem is intractable, it might be possible for DUK to promote the drawing up of a code of practice for HCP responses to T2 diabetic requests for testing strips, so that patients are not actively dissuaded from testing with false information.
They agreed to bring the topic up for discussion by their policy team, and I have now been told that, while the Healthcare Professional Engagement team felt they have insufficient capacity for this to be a significant piece of work, they do see the importance of the issue. They may therefore run this as a story in one of their newsletters for healthcare professionals this year.
It’s a start, then.
I wrote to Diabetes UK, noting from their 2013 report on access to test-strips (thanks to Phoenix for the link) the extraordinary range of misleading responses given by HCPs in telling people why test strips cannot be provided, and noting especially those cases where diabetics are told that testing is unnecessary or even positively harmful. I remarked that this meant that not only are diabetics not receiving test strips, but they are being positively dissuaded from buying their own and using them to monitor their condition. Using examples from this thread, I commented that the reasons given (stress, pain from use of lancets or risk of infection, ‘testing does not work’, etc) ranged from the misleading to the outrageously false. I suggested that, even if the financial problem is intractable, it might be possible for DUK to promote the drawing up of a code of practice for HCP responses to T2 diabetic requests for testing strips, so that patients are not actively dissuaded from testing with false information.
They agreed to bring the topic up for discussion by their policy team, and I have now been told that, while the Healthcare Professional Engagement team felt they have insufficient capacity for this to be a significant piece of work, they do see the importance of the issue. They may therefore run this as a story in one of their newsletters for healthcare professionals this year.
It’s a start, then.